Suchergebnisse - "Zimlichman, R"

PubPharm (171)

1

Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778 : a proof-of-concept study in patients with mild-to-moderate essential hypertension

enthalten in: Journal of human hypertension | 2015

von Dingemanse, J. | Otasevic, P. | Shakeri-Nejad, K. | +5

2

Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertension

enthalten in: Journal of human hypertension | 2015

von Dingemanse, J. | Otasevic, P. | Shakeri-Nejad, K. | +5

3

Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack : a predefined subgroup analysis from AVERROES, a randomised trial

enthalten in: The Lancet. Neurology | 2012

von Diener, H. | Eikelboom, J. | Connolly, S. | +109

CommentIn: Lancet Neurol. 2012 Mar;11(3):203-5. - PMID 22341027

4

Subclinical atrial fibrillation and the risk of stroke

enthalten in: The New England journal of medicine | 2012

von Healey, J. | Connolly, S. | Gold, M. | +113

CommentIn: N Engl J Med. 2012 Jan 12;366(2):178-80. - PMID 22236229

5

Dronedarone in high-risk permanent atrial fibrillation

enthalten in: The New England journal of medicine | 2011

von Connolly, S. | Camm, A. | Halperin, J. | +153

ErratumIn: N Engl J Med. 2012 Feb 16;366(7):672

6

Early drop in systolic blood pressure and worsening renal function in acute heart failure : renal results of Pre-RELAX-AHF

enthalten in: European journal of heart failure | 2011

von Voors, A. | Davison, B. | Felker, G. | +62

7

Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL) : a randomised, parallel group, multicentre trial

enthalten in: Lancet (London, England) | 2011

von Jolly, S. | Yusuf, S. | Cairns, J. | +116

ErratumIn: Lancet. 2011 Apr 23;377(9775):1408

8

Differential clinical profile of candesartan compared to other angiotensin receptor blockers

in: Vascular Health and Risk Management | 2011

von Zimlichman R

9

Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome : results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial

enthalten in: Circulation | 2009

von APPRAISE Steering Committee and Investigators | Alexander, J. | Becker, R. | +117

10

High dose treatment with angiotensin II receptor blocker in patients with hypertension : differential effect of tissue protection versus blood pressure lowering

enthalten in: Atherosclerosis | 2008

von Shargorodsky, M. | Hass, E. | Boaz, M. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]